These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 24617517)

  • 1. Patients' information-seeking activity is associated with treatment compliance in inflammatory bowel disease patients.
    Pittet V; Rogler G; Mottet C; Froehlich F; Michetti P; de Saussure P; Burnand B; Vader JP;
    Scand J Gastroenterol; 2014 Jun; 49(6):662-73. PubMed ID: 24617517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence to medical treatment in inflammatory bowel disease patients.
    Zelante A; De Giorgi A; Borgoni R; Trevisani L; Gallerani M
    Minerva Gastroenterol Dietol; 2014 Dec; 60(4):269-74. PubMed ID: 25384805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Information resources used by patients with inflammatory bowel disease: Satisfaction, expectations and information gaps.
    Catalán-Serra I; Huguet-Malavés JM; Mínguez M; Torrella E; Paredes JM; Vázquez N; Ramírez JJ; Calvo F; Nos P; Gutiérrez A; Palau A; Cortés J; Ramón-Monllor P; Hinojosa J
    Gastroenterol Hepatol; 2015; 38(6):355-63. PubMed ID: 25813702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. May you never forget what is worth remembering: the relation between recall of medical information and medication adherence in patients with inflammatory bowel disease.
    Linn AJ; van Dijk L; Smit EG; Jansen J; van Weert JC
    J Crohns Colitis; 2013 Dec; 7(11):e543-50. PubMed ID: 23660489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disease-related worries and concerns: a study on out-patients with inflammatory bowel disease.
    Moser G; Tillinger W; Sachs G; Genser D; Maier-Dobersberger T; Spiess K; Wyatt J; Vogelsang H; Lochs H; Gangl A
    Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):853-8. PubMed ID: 8574717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A national survey on the patterns of treatment of inflammatory bowel disease in Canada.
    Hilsden RJ; Verhoef MJ; Best A; Pocobelli G
    BMC Gastroenterol; 2003 Jun; 3():10. PubMed ID: 12791168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depressive Symptoms Predict Anti-tumor Necrosis Factor Therapy Noncompliance in Patients with Inflammatory Bowel Disease.
    Calloway A; Dalal R; Beaulieu DB; Duley C; Annis K; Gaines L; Slaughter C; Schwartz DA; Horst S
    Dig Dis Sci; 2017 Dec; 62(12):3563-3567. PubMed ID: 29052816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Information Needs and Concerns of Patients with Inflammatory Bowel Disease: What Can We Learn from Participants in a Bilingual Clinical Cohort?
    Pittet V; Vaucher C; Maillard MH; Girardin M; de Saussure P; Burnand B; Rogler G; Michetti P
    PLoS One; 2016; 11(3):e0150620. PubMed ID: 26939069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of complementary and alternative medicine on the quality of life in inflammatory bowel disease: results from a French national survey.
    Abitbol V; Lahmek P; Buisson A; Olympie A; Poupardin C; Chaussade S; Lesgourgues B; Nahon S
    Eur J Gastroenterol Hepatol; 2014 Mar; 26(3):288-94. PubMed ID: 24407360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosuppressive therapy in pediatric inflammatory bowel disease: results of a survey of the North American Society for Pediatric Gastroenterology and Nutrition. Subcommittee on Immunosuppressive Use of the Pediatric IBD Collaborative Research Forum.
    Markowitz J; Grancher K; Mandel F; Daum F
    Am J Gastroenterol; 1993 Jan; 88(1):44-8. PubMed ID: 8420272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterisation of complementary and alternative medicine use and its impact on medication adherence in inflammatory bowel disease.
    Weizman AV; Ahn E; Thanabalan R; Leung W; Croitoru K; Silverberg MS; Steinhart AH; Nguyen GC
    Aliment Pharmacol Ther; 2012 Feb; 35(3):342-9. PubMed ID: 22176478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A survey of current practice of venous thromboembolism prophylaxis in hospitalized inflammatory bowel disease patients in the United States.
    Tinsley A; Naymagon S; Trindade AJ; Sachar DB; Sands BE; Ullman TA
    J Clin Gastroenterol; 2013 Jan; 47(1):e1-6. PubMed ID: 22476043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sources of information and factual knowledge in Europeans with inflammatory bowel diseases: a cross-cultural comparison between German and Irish patients.
    Blumenstein I; McDermott E; Keegan D; Byrne K; Ellison M; Doherty G; Schröder O; Mulcahy H
    J Crohns Colitis; 2013 Oct; 7(9):e331-6. PubMed ID: 23453429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between corticosteroid use and development of fractures among IBD patients in a population-based database.
    Bernstein CN; Blanchard JF; Metge C; Yogendran M
    Am J Gastroenterol; 2003 Aug; 98(8):1797-801. PubMed ID: 12907335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perceptions of medication safety among patients with inflammatory bowel disease.
    Cullen G; Donnellan F; Long S; Forry M; Murray FE
    Scand J Gastroenterol; 2010 Sep; 45(9):1076-83. PubMed ID: 20459367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perceptions and Attitudes Towards Medication Adherence during Pregnancy in Inflammatory Bowel Disease.
    Gallinger ZR; Rumman A; Nguyen GC
    J Crohns Colitis; 2016 Aug; 10(8):892-7. PubMed ID: 26896087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory Bowel Disease in the COVID-19 Pandemic: the Patients' Perspective.
    Grunert PC; Reuken PA; Stallhofer J; Teich N; Stallmach A
    J Crohns Colitis; 2020 Dec; 14(12):1702-1708. PubMed ID: 32564068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased risk for demyelinating diseases in patients with inflammatory bowel disease.
    Gupta G; Gelfand JM; Lewis JD
    Gastroenterology; 2005 Sep; 129(3):819-26. PubMed ID: 16143121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E-health: Web-guided therapy and disease self-management in ulcerative colitis. Impact on disease outcome, quality of life and compliance.
    Elkjaer M
    Dan Med J; 2012 Jul; 59(7):B4478. PubMed ID: 22759851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
    Burisch J
    Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.